Edwards Lifesciences Price to Book Ratio 2010-2024 | EW
Historical price to book ratio values for Edwards Lifesciences (EW) over the last 10 years. The current price to book ratio for Edwards Lifesciences as of February 14, 2025 is 4.45.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Edwards Lifesciences Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2025-02-14 | 76.19 | 4.68 | |
2024-09-30 | 65.99 | $16.30 | 4.05 |
2024-06-30 | 92.37 | $12.46 | 7.41 |
2024-03-31 | 95.56 | $11.93 | 8.01 |
2023-12-31 | 76.25 | $11.18 | 6.82 |
2023-09-30 | 69.28 | $11.09 | 6.25 |
2023-06-30 | 94.33 | $10.60 | 8.90 |
2023-03-31 | 82.73 | $10.00 | 8.27 |
2022-12-31 | 74.61 | $9.55 | 7.82 |
2022-09-30 | 82.63 | $10.04 | 8.23 |
2022-06-30 | 95.09 | $9.59 | 9.92 |
2022-03-31 | 117.72 | $9.41 | 12.52 |
2021-12-31 | 129.55 | $9.35 | 13.85 |
2021-09-30 | 113.21 | $8.88 | 12.75 |
2021-06-30 | 103.57 | $8.24 | 12.57 |
2020-12-31 | 91.23 | $7.33 | 12.45 |
2020-09-30 | 79.82 | $6.76 | 11.81 |
2020-06-30 | 69.11 | $6.18 | 11.19 |
2020-03-31 | 62.87 | $6.30 | 9.98 |
2019-12-31 | 77.76 | $19.84 | 3.92 |
2021-03-31 | 83.64 | $7.49 | 11.16 |
2019-09-30 | 73.30 | $6.10 | 12.02 |
2019-06-30 | 61.58 | $5.61 | 10.97 |
2019-03-31 | 63.78 | $5.51 | 11.57 |
2018-12-31 | 51.06 | $5.04 | 10.13 |
2018-09-30 | 58.03 | $5.36 | 10.83 |
2018-06-30 | 48.52 | $5.04 | 9.62 |
2018-03-31 | 46.51 | $5.13 | 9.06 |
2017-12-31 | 37.57 | $4.70 | 8.00 |
2017-09-30 | 36.44 | $4.98 | 7.31 |
2017-06-30 | 39.41 | $4.64 | 8.49 |
2017-03-31 | 31.36 | $4.35 | 7.22 |
2016-12-31 | 31.23 | $4.13 | 7.57 |
2016-09-30 | 40.19 | $4.20 | 9.57 |
2016-06-30 | 33.24 | $3.87 | 8.58 |
2016-03-31 | 29.40 | $3.62 | 8.13 |
2015-12-31 | 26.33 | $3.87 | 6.80 |
2015-09-30 | 23.70 | $3.75 | 6.32 |
2015-06-30 | 23.74 | $3.55 | 6.68 |
2015-03-31 | 23.74 | $3.43 | 6.92 |
2014-12-31 | 21.23 | $6.78 | 3.13 |
2014-09-30 | 17.03 | $3.19 | 5.34 |
2014-06-30 | 14.31 | $3.01 | 4.75 |
2013-12-31 | 10.96 | $2.36 | 4.65 |
2013-09-30 | 11.61 | $2.19 | 5.30 |
2013-06-30 | 11.20 | $2.35 | 4.77 |
2013-03-31 | 13.69 | $2.34 | 5.86 |
2012-12-31 | 15.03 | $2.16 | 6.97 |
2014-03-31 | 12.36 | $2.12 | 5.82 |
2012-09-30 | 17.90 | $2.21 | 8.11 |
2012-06-30 | 17.22 | $2.07 | 8.30 |
2012-03-31 | 12.12 | $2.03 | 5.96 |
2011-12-31 | 11.78 | $1.95 | 6.03 |
2011-09-30 | 11.88 | $1.98 | 6.01 |
2011-06-30 | 14.53 | $2.01 | 7.23 |
2011-03-31 | 14.50 | $1.97 | 7.36 |
2010-12-31 | 13.47 | $1.90 | 7.11 |
2010-09-30 | 11.18 | $1.80 | 6.20 |
2010-06-30 | 9.34 | $1.65 | 5.67 |
2010-03-31 | 8.24 | $1.69 | 4.88 |
2009-12-31 | 7.24 | $3.40 | 2.13 |
2009-09-30 | 5.83 | $1.61 | 3.62 |
2009-06-30 | 5.67 | $1.48 | 3.83 |
2009-03-31 | 5.05 | $1.40 | 3.60 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $41.870B | $6.005B |
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $219.062B | 26.20 |
Intuitive Surgical (ISRG) | United States | $209.612B | 96.16 |
Alcon (ALC) | Switzerland | $45.206B | 30.25 |
IQVIA Holdings (IQV) | United States | $38.108B | 20.48 |
IDEXX Laboratories (IDXX) | United States | $37.713B | 43.16 |
DexCom (DXCM) | United States | $34.497B | 51.95 |
Mettler-Toledo (MTD) | United States | $28.642B | 32.97 |
Waters (WAT) | United States | $24.401B | 36.08 |
STERIS (STE) | Ireland | $22.253B | 25.33 |
SONOVA HOLDING (SONVY) | Switzerland | $20.160B | 0.00 |
Hologic (HOLX) | United States | $14.774B | 15.85 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $14.260B | 14.64 |
Globus Medical (GMED) | United States | $11.976B | 30.33 |
Sysmex ADR (SSMXY) | Japan | $11.771B | 36.91 |
Penumbra (PEN) | United States | $10.036B | 98.31 |
Masimo (MASI) | United States | $9.638B | 46.64 |
Glaukos (GKOS) | United States | $8.562B | 0.00 |
Teleflex (TFX) | United States | $8.064B | 12.86 |
Integer Holdings (ITGR) | United States | $4.726B | 26.79 |
Inari Medical (NARI) | United States | $4.676B | 0.00 |
PROCEPT BioRobotics (PRCT) | United States | $3.694B | 0.00 |
Veracyte (VCYT) | United States | $3.371B | 101.16 |
Nihon Kohden (NHNKY) | Japan | $2.700B | 14.76 |
LivaNova (LIVN) | United Kingdom | $2.605B | 15.04 |
TransMedics (TMDX) | United States | $2.467B | 78.19 |
Tandem Diabetes Care (TNDM) | United States | $2.413B | 0.00 |
Elekta AB (EKTAY) | Sweden | $2.332B | 20.97 |
Integra LifeSciences Holdings (IART) | United States | $2.008B | 10.49 |
Alphatec Holdings (ATEC) | United States | $1.620B | 0.00 |
RxSight (RXST) | United States | $1.353B | 0.00 |
Pulse Biosciences (PLSE) | United States | $1.340B | 0.00 |
Artivion (AORT) | United States | $1.311B | 86.86 |
OPKO Health (OPK) | United States | $1.106B | 0.00 |
Paragon 28 (FNA) | United States | $1.088B | 0.00 |
AxoGen (AXGN) | United States | $0.807B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.781B | 13.27 |
IRadimed (IRMD) | United States | $0.778B | 42.03 |
Mesa Laboratories (MLAB) | United States | $0.770B | 16.83 |
SiBone (SIBN) | United States | $0.725B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.706B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.640B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.574B | 0.00 |
Delcath Systems (DCTH) | United States | $0.526B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.521B | 0.00 |
Semler Scientific (SMLR) | United States | $0.463B | 24.35 |
AngioDynamics (ANGO) | United States | $0.449B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.438B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.412B | 22.30 |
NeuroPace (NPCE) | United States | $0.408B | 0.00 |
CVRx (CVRX) | United States | $0.357B | 0.00 |
Accuray (ARAY) | United States | $0.277B | 0.00 |
Inogen (INGN) | United States | $0.258B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.226B | 0.00 |
Anteris Technologies Global (AVR) | Australia | $0.222B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.222B | 0.00 |
Nevro (NVRO) | United States | $0.214B | 0.00 |
Sight Sciences (SGHT) | United States | $0.138B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.133B | 0.00 |
LENSAR (LNSR) | United States | $0.126B | 0.00 |
Hyperfine (HYPR) | United States | $0.125B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.118B | 0.00 |
Neuronetics (STIM) | United States | $0.108B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.101B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.100B | 15.20 |
Monogram Orthopaedics (MGRM) | United States | $0.095B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.092B | 0.00 |
908 Devices (MASS) | United States | $0.089B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.081B | 0.00 |
InspireMD (NSPR) | Israel | $0.068B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.061B | 31.57 |
Lucid Diagnostics (LUCD) | United States | $0.057B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.055B | 0.00 |
Positron (POSC) | United States | $0.053B | 0.00 |
Microbot Medical (MBOT) | United States | $0.044B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.039B | 0.00 | |
Spectral AI (MDAI) | United States | $0.037B | 0.00 |
Precision Optics (POCI) | United States | $0.032B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.032B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.032B | 0.00 |
Envoy Medical (COCH) | United States | $0.032B | 0.00 |
NexGel (NXGL) | United States | $0.023B | 0.00 |
DarioHealth (DRIO) | United States | $0.021B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
PAVmed (PAVM) | United States | $0.007B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.006B | 0.00 |
Nuwellis (NUWE) | United States | $0.005B | 0.00 |
Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
Tenon Medical (TNON) | United States | $0.005B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.004B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Venus Concept (VERO) | Canada | $0.003B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Avinger (AVGR) | United States | $0.001B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |